Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2010-03-08 12:00:00
Reporting Period:
Filing Date:
Accepted Time:
2010-03-08 10:38:10
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
879993 Dusa Pharmaceuticals Inc DUSA Pharmaceutical Preparations (2834) 223103129
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1138558 M Jay Haft 110 East 57Th Street
Suite 14A
New York NY 10022
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-03-05 10,000 $1.72 25,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 34,500 Indirect by wife
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.68010 to $1.75010, inclusive. The reporting person undertakes to provide to DUSA Pharmaceuticals, Inc., any security holder of DUSA Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
  2. Includes Stock Awards which vest at the rate of one-quarter of the total grant on each of the first, second, third and fourth anniversaries of the date of the grant.